← All companies

VCRE

Vicore Pharma Holding AB (publ)

VCRE Nasdaq Pharmaceutical Preparations EDGAR ↗

$9.52

-0.07 -0.73%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$8.79 – $17.80

Recent SEC filings

8 most recent

Annual, quarterly & current reports

6-K FORM 6-K Aug 21, 2026

6-K FORM 6-K Jul 6, 2026

Other filings

S-8 FORM S-8 Aug 21, 2026

SEC STAFF ACTION Jun 30, 2026

CERT Jun 30, 2026

20FR12B/A Jun 9, 2026

20FR12B May 22, 2026

DRS Apr 17, 2026